| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cytokinetics, Incorporated (CYTK) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. CYTK is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 400.3K | $32.51M | - | |
| VP | 153.9K | $12.50M | -3,500 | |
| Other | 87.3K | $7.09M | - | |
| VP | 73.6K | $5.97M | -15,000 | |
| CFO | 70.1K | $5.69M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 21, 2020 | Jaw Ching47 | SVP Finance &CFO | Sale+OE | 25,000 | $25.00 | $625,000.00 | -14.6% | |
| Aug 21, 2020 | Schlossberg Mark A | SVP - Legal &General Counsel | Sale+OE | 10,000 | $25.00 | $250,000.00 | -25.0% | |
| Aug 18, 2020 | Blum Robert I51 | President &CEO | Sale+OE | 5,000 | $23.48 | $117,422.00 | -1.6% | |
| Aug 13, 2020 | Malik Fady Ibraham55 | EVP Research &Development | Sell | 599 | $21.85 | $13,088.15 | -0.4% | |
| Aug 5, 2020 | Blum Robert I51 | President &CEO | Sale+OE | 5,000 | $22.12 | $110,621.00 | -1.6% | |
| Jul 29, 2020 | Schlossberg Mark A | SVP - Legal &General Counsel | Sale+OE | 10,000 | $23.07 | $230,728.00 | -25.0% | |
| Jul 28, 2020 | Blum Robert I51 | President &CEO | Sale+OE | 5,000 | $23.77 | $118,829.00 | -1.6% | |
| Jul 16, 2020 | Blum Robert I51 | President &CEO | Sale+OE | 5,000 | $27.36 | $136,805.50 | -1.6% | |
| Jul 15, 2020 | Smith Sandford D48 | Director | Sale+OE | 6,667 | $29.00 | $193,343.00 | -100% | |
| Jul 10, 2020 | Smith Sandford D48 | Director | Sale+OE | 6,667 | $28.00 | $186,676.00 | -100% |